These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7778055

  • 1. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood.
    Anfossi G, Parisi S, Russo I, Mularoni EM, Massucco P, Cavalot F, Mattiello L, Trovati M.
    Thromb Res; 1995 Mar 01; 77(5):399-410. PubMed ID: 7778055
    [Abstract] [Full Text] [Related]

  • 2. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M, Tenconi PM, Lecchi A, Mannucci PM.
    Thromb Res; 1991 Jun 15; 62(6):717-24. PubMed ID: 1926062
    [Abstract] [Full Text] [Related]

  • 3. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets.
    Berrettini M, De Cunto M, Parise P, Grasselli S, Nenci GG.
    Eur J Clin Pharmacol; 1990 Jun 15; 39(5):495-500. PubMed ID: 1963845
    [Abstract] [Full Text] [Related]

  • 4. Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist.
    Modesti PA, Cecioni I, Colella A, Costoli A, Paniccia R, Neri Serneri GG.
    Br J Pharmacol; 1994 May 15; 112(1):81-6. PubMed ID: 8032666
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of the effect of picotamide on platelet function in diabetic subjects].
    Carleo R, Veno L, Fuccio F, Bonavita M, De Matteo A, Gallo M, Gatti A, Gobbo M, Nocerino L.
    Boll Soc Ital Biol Sper; 1990 Jul 15; 66(7):647-54. PubMed ID: 2083059
    [Abstract] [Full Text] [Related]

  • 6. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P, Deckmyn H, Arnout J, Nenci GG, Vermylen J.
    Thromb Haemost; 1989 Jun 30; 61(3):479-84. PubMed ID: 2552606
    [Abstract] [Full Text] [Related]

  • 7. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G, Perini F, Hasselmark L, Alecci M, Cananzi AR.
    Funct Neurol; 1995 Jun 30; 10(2):91-8. PubMed ID: 7557557
    [Abstract] [Full Text] [Related]

  • 8. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
    Violi F, Ghiselli A, Iuliano L, Praticò D, Alessandri C, Balsano F.
    Eur J Clin Pharmacol; 1988 Jun 30; 33(6):599-602. PubMed ID: 3366163
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of the persisting TxA2 receptor antagonism by picotamide.
    Pulcinelli FM, Pignatelli P, Pesciotti M, Sebastiani S, Parisi S, Gazzaniga PP.
    Thromb Res; 1997 Feb 01; 85(3):207-15. PubMed ID: 9058495
    [Abstract] [Full Text] [Related]

  • 10. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM, Pignatelli P, Riondino S, Parisi S, Castiglioni C, Gazzaniga PP.
    Thromb Res; 1994 Jun 01; 74(5):453-61. PubMed ID: 8085246
    [Abstract] [Full Text] [Related]

  • 11. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.
    Vezza R, Spina D, Tallarida RJ, Nathan M, Page CP, Gresele P.
    Thromb Haemost; 1997 Nov 01; 78(5):1385-91. PubMed ID: 9408024
    [Abstract] [Full Text] [Related]

  • 12. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb 01; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 13. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H, Stegmeier K.
    Thromb Res; 1984 Feb 01; 33(3):277-88. PubMed ID: 6424261
    [Abstract] [Full Text] [Related]

  • 14. Competitive inhibition of platelet thromboxane A2 receptor binding by picotamide.
    Modesti PA, Colella A, Abbate R, Gensini G, Neri Serneri G.
    Eur J Pharmacol; 1989 Oct 04; 169(1):85-93. PubMed ID: 2532145
    [Abstract] [Full Text] [Related]

  • 15. Platelet aggregation in human whole blood after chronic administration of aspirin.
    de la Cruz JP, Camara S, Bellido I, Carrasco T, Sanchez de la Cuesta F.
    Thromb Res; 1987 Apr 01; 46(1):133-40. PubMed ID: 3109069
    [Abstract] [Full Text] [Related]

  • 16. Effects of acetylsalicylic acid on platelet aggregation in male and female whole blood: an in vitro study.
    de la Cruz JP, Bellido I, Camara S, Martos F, Sanchez de la Cuesta F.
    Scand J Haematol; 1986 Apr 01; 36(4):394-7. PubMed ID: 3086967
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN, Hsiao G, Chen IS, Wu SJ, Teng CM.
    Biochem Pharmacol; 1993 Oct 05; 46(7):1165-73. PubMed ID: 8216367
    [Abstract] [Full Text] [Related]

  • 18. Dose-responses to inducers and inhibitors of platelet aggregation analysed via a micro-method.
    Hoylaerts MF, Thys C, Stassen JM, Vermylen J.
    Blood Coagul Fibrinolysis; 1996 Mar 05; 7(2):187-90. PubMed ID: 8735815
    [Abstract] [Full Text] [Related]

  • 19. Platelet antiaggregatory effect of triflusal in human whole blood.
    de la Cruz JP, Pavia J, Bellido I, González MC, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1988 Apr 05; 10(4):273-7. PubMed ID: 3386335
    [Abstract] [Full Text] [Related]

  • 20. Effects of trifluoperazine on platelet activation.
    Ardlie NG, Boatwright C, Garrett J, McGuiness JA.
    Thromb Res; 1985 Jun 15; 38(6):695-706. PubMed ID: 3161211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.